We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

WEBINAR ON DISCLOSURE OF CLINICAL TRIAL DATA IN THE EUROPEAN UNION: WHAT ARE THE IMPLICATIONS OF NEW RULES

28 April 20155:00 PM - 6:00 PM (CET)

The recent publication by the European Medicines Agency of its policy on the proactive publication of clinical data for medicinal products, combined with the new Clinical Trials Regulation, the Joint EFPIA-PhRMA Principles for Responsible Clinical Trial Data Sharing and the existing EMA Access to Documents policy has arguably led to a sense of confusion amongst pharmaceutical companies concerning the overall framework governing the disclosure of clinical trial data in the European Union.

You are invited to a 60-minute webinar presented by Hogan Lovells Partner Elisabethann Wright and Associate Ciara Farrell.

During this webinar, our speakers will draw comparisons between disclosure obligations provided by the new EMA disclosure policy, the new Clinical Trials Regulation, the EMA's access to documents procedure, and the PhRMA-EFPIA joint principles for responsible clinical trial data sharing.

If you would like to attend please register for the webinar here.

28 April 2015
5:00 PM - 6:00 PM (CET)

Speaker list

Loading data